News

Day Zero Diagnostics Secures Additional $8.2M From CARB-X

Day Zero Diagnostics Secures Additional $8.2M From CARB-X

GenomeWeb | NEW YORK – Day Zero Diagnostics said on Thursday that it has been granted an additional $8.2 million in funding from the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X, a global nonprofit organization.

Full Story